Literature DB >> 25747176

CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study.

Yau-Hua Yu1, Jose Morales2, Lei Feng3, J Jack Lee3, Adel K El-Naggar3, Nadarajah Vigneswaran4.   

Abstract

OBJECTIVE: Squamous cell carcinoma of the oral tongue (SCCOT) exhibits high risk for recurrence and regional metastasis even after surgical resection. We assessed the clinicopathologic and prognostic significance of a group of functionally related biomarkers. STUDY
DESIGN: We used a tissue microarray consisting of SCCOT from 32 patients for this study. These patients were treated at the University of Texas MD Anderson Cancer Center from 1995 to 2008. Biomarker expression levels were examined by immunohistochemistry and graded semiquantitatively to determine their prognostic significance.
RESULTS: CD147 and Tp63 expressions were significantly associated with a higher T stage and Ki-67 labeling index, as well as a shorter overall survival (OS) rate. Expression of Tp63 associated positively with poorly differentiated histology. There was significant association of Tp63 with the expression levels of CD147 and Glut-1. Glut-1 overexpression was marginally associated with a higher T stage. There was no prognostic significance of CD44 v6 expression in SCCOT.
CONCLUSION: SCCOT with CD147 overexpression in combination with high Ki-67 labeling index had poor OS. CD147 and Ki-67 overexpression is associated with aggressive disease with poor prognosis in SCCOT.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25747176      PMCID: PMC4397137          DOI: 10.1016/j.oooo.2014.12.022

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  87 in total

1.  Expression of emmprin by oral squamous cell carcinoma.

Authors:  L C Bordador; X Li; B Toole; B Chen; J Regezi; L Zardi; Y Hu; D M Ramos
Journal:  Int J Cancer       Date:  2000-02-01       Impact factor: 7.396

2.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 3.  Epidemiologic trends in head and neck cancer and aids in diagnosis.

Authors:  Nadarajah Vigneswaran; Michelle D Williams
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2014-05       Impact factor: 2.802

4.  Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts.

Authors:  Takuro Kanekura; Xiang Chen; Tamotsu Kanzaki
Journal:  Int J Cancer       Date:  2002-06-01       Impact factor: 7.396

5.  Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions.

Authors:  K Nylander; P J Coates; P A Hall
Journal:  Int J Cancer       Date:  2000-08-01       Impact factor: 7.396

6.  Combined transcriptome and genome analysis of single micrometastatic cells.

Authors:  Christoph A Klein; Stefan Seidl; Karina Petat-Dutter; Sonja Offner; Jochen B Geigl; Oleg Schmidt-Kittler; Nicole Wendler; Bernward Passlick; Rudolf M Huber; Günter Schlimok; Patrick A Baeuerle; Gert Riethmüller
Journal:  Nat Biotechnol       Date:  2002-04       Impact factor: 54.908

7.  Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.

Authors:  Xin-Qiong Huang; Xiang Chen; Xiao-Xue Xie; Qin Zhou; Kai Li; Shan Li; Liang-Fang Shen; Juan Su
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

8.  Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma.

Authors:  Eben L Rosenthal; Satya Shreenivas; Glenn E Peters; William E Grizzle; Renee Desmond; Candece L Gladson
Journal:  Laryngoscope       Date:  2003-08       Impact factor: 3.325

9.  Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells.

Authors:  Min Jueng Kang; Hwang-Phill Kim; Kyeong-seob Lee; Young-Dong Yoo; Yong-Tae Kwon; Kristine M Kim; Tae-You Kim; Eugene C Yi
Journal:  Proteomics       Date:  2013-04-23       Impact factor: 3.984

10.  SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.

Authors:  Hideo Watanabe; Qiuping Ma; Shouyong Peng; Guillaume Adelmant; Danielle Swain; Wenyu Song; Cameron Fox; Joshua M Francis; Chandra Sekhar Pedamallu; David S DeLuca; Angela N Brooks; Su Wang; Jianwen Que; Anil K Rustgi; Kwok-kin Wong; Keith L Ligon; X Shirley Liu; Jarrod A Marto; Matthew Meyerson; Adam J Bass
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

View more
  15 in total

1.  Prognostic significance of monocarboxylate transporter expression in oral cavity tumors.

Authors:  Susana Simões-Sousa; Sara Granja; Céline Pinheiro; Daniela Fernandes; Adhemar Longatto-Filho; Ana Carolina Laus; Cira Danielle Casado Alves; J M Suárez-Peñaranda; Mario Pérez-Sayáns; Andre Lopes Carvalho; Fernando C Schmitt; Abel García-García; Fatima Baltazar
Journal:  Cell Cycle       Date:  2016-05-27       Impact factor: 4.534

2.  'Cytology-on-a-chip' based sensors for monitoring of potentially malignant oral lesions.

Authors:  Timothy J Abram; Pierre N Floriano; Nicolaos Christodoulides; Robert James; A Ross Kerr; Martin H Thornhill; Spencer W Redding; Nadarajah Vigneswaran; Paul M Speight; Julie Vick; Craig Murdoch; Christine Freeman; Anne M Hegarty; Katy D'Apice; Joan A Phelan; Patricia M Corby; Ismael Khouly; Jerry Bouquot; Nagi M Demian; Y Etan Weinstock; Stephanie Rowan; Chih-Ko Yeh; H Stan McGuff; Frank R Miller; Surabhi Gaur; Kailash Karthikeyan; Leander Taylor; Cathy Le; Michael Nguyen; Humberto Talavera; Rameez Raja; Jorge Wong; John T McDevitt
Journal:  Oral Oncol       Date:  2016-07-20       Impact factor: 5.337

Review 3.  CD147 and glioma: a meta-analysis.

Authors:  Hui Li; Zhouhuan Xi; Xuejiao Dai; Wenyue Wu; Yanwen Li; Yanting Liu; Hanwen Zhang
Journal:  J Neurooncol       Date:  2017-05-30       Impact factor: 4.130

4.  Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review.

Authors:  Raissa Borges Curtarelli; Jussara Maria Gonçalves; Luciane Geanini Pena Dos Santos; Maria Gorete Savi; Jacques Eduardo Nör; Luis André Mendonça Mezzomo; Mabel Mariela Rodríguez Cordeiro
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

5.  Integrative analysis of BSG expression in NPC through immunohistochemistry and public high-throughput gene expression data.

Authors:  Li Gao; Jin-Cai Zhong; Wen-Ting Huang; Yi-Wu Dang; Min Kang; Gang Chen
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

6.  The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies.

Authors:  Hengwei Fan; Wanwan Yi; Chenxing Wang; Jisheng Wang
Journal:  Oncotarget       Date:  2017-07-31

Review 7.  Cancer Stem Cells in Oral Cavity Squamous Cell Carcinoma: A Review.

Authors:  Ranui Baillie; Swee T Tan; Tinte Itinteang
Journal:  Front Oncol       Date:  2017-06-02       Impact factor: 6.244

Review 8.  Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.

Authors:  Cory D Bovenzi; James Hamilton; Patrick Tassone; Jennifer Johnson; David M Cognetti; Adam Luginbuhl; William M Keane; Tingting Zhan; Madalina Tuluc; Voichita Bar-Ad; Ubaldo Martinez-Outschoorn; Joseph M Curry
Journal:  Biomed Res Int       Date:  2015-12-08       Impact factor: 3.411

9.  Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma.

Authors:  Eduardo-Pereira Guimarães; Marina-Lara de Carli; Felipe-Fornias Sperandio; João-Adolfo-Costa Hanemann; Alessandro-Antônio-Costa Pereira
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-11-01

10.  Expression and clinical significance of CD147 in renal cell carcinoma: a meta-analysis.

Authors:  Hui Li; Dongwen Wu; Shupeng Shi; Yadong Xu; Ling Wei; Jing Liu; Yanting Liu
Journal:  Oncotarget       Date:  2017-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.